The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2020

Filed:

May. 26, 2017
Applicant:

Psomagen, Inc., Rockville, MD (US);

Inventors:

Zachary Apte, San Francisco, CA (US);

Jessica Richman, San Francisco, CA (US);

Daniel Almonacid, San Francisco, CA (US);

Assignee:

PSOMAGEN, INC., Rockville, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/48 (2006.01); G16H 40/67 (2018.01); G16B 50/00 (2019.01); C12Q 1/68 (2018.01); C12Q 1/6883 (2018.01); C12Q 1/689 (2018.01); G06F 19/00 (2018.01); G16H 50/20 (2018.01); G16H 20/10 (2018.01); G16B 99/00 (2019.01); G16B 5/00 (2019.01); G16H 50/50 (2018.01); G06G 7/58 (2006.01);
U.S. Cl.
CPC ...
G16H 40/67 (2018.01); C12Q 1/68 (2013.01); C12Q 1/689 (2013.01); C12Q 1/6883 (2013.01); G06F 19/30 (2013.01); G06F 19/3418 (2013.01); G16B 5/00 (2019.02); G16B 50/00 (2019.02); G16B 99/00 (2019.02); G16H 20/10 (2018.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01); C12Q 2600/118 (2013.01); Y02A 90/26 (2018.01);
Abstract

A method for diagnosing and treating an immune microbial dysfunction in a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the immune microbial dysfunction based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset, wherein the characterization is diagnostic of at least one of Crohn's disease, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), ulcerative colitis, and celiac disease; based upon the characterization, generating a therapy model configured to correct the immune microbial dysfunction; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.


Find Patent Forward Citations

Loading…